Genetics and phenomics of hypothyroidism and goiter due to NIS mutations

Molecular and Cellular Endocrinology

Volumn 322, Issue 1-2, 2010, Pages 56-63

  Spitzweg, Christine ^a   Morris, John C ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

Congenital hypothyroidism; Iodide transport defect; NIS mutations; Sodium iodide symporter (NIS)

Indexed keywords

SODIUM IODIDE SYMPORTER;

BIOMICS; CHROMOSOME 19P; CONGENITAL HYPOTHYROIDISM; FAMILY HISTORY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC COUNSELING; GENOTYPE PHENOTYPE CORRELATION; GOITER; HUMAN; HYPOTHYROIDISM; ION TRANSPORT; JAPANESE; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; PATHOGENESIS; PHENOMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; THYROID FUNCTION;

EID: 77952880343     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.02.007     Document Type: Review

References (77)

1. Ajjan R.A., Kamaruddin N.A., Crisp M., Watson P.F., Ludgate M., Weetman A.P. Regulation and tissue distribution of the human sodium iodide symporter gene. Clin. Endocrinol. 1998, 49:517-523.
2. Ajjan R.A., Watson P.F., Findlay C., Metcalfe R.A., Crisp M., Ludgate M., Weetman A.P. The sodium iodide symporter gene and its regulation by cytokines found in autoimmunity. J. Endocrinol. 1998, 158:351-358.
3. Bizhanova A., Kopp P. Minireview: the sodium iodide symporter NIS and pendrin in iodide homeostasis of the thyroid. Endocrinology 2009, 150:1084-1090.
4. Carrasco N. Iodide transport in the thyroid gland. Biochem. Biophys. Acta 1993, 1154:65-82.
5. Caturegli P., Hejazi M., Suzuki K., Dohan O., Carrasco N., Kohn L.D., Rose N.R. Hypothyroidism in transgenic mice expressing IFN-g in the thyroid. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:1719-1724.
6. Cengic N., Baker C.H., Schutz M., Göke B., Morris J.C., Spitzweg C. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression. J. Clin. Endocrinol. Metab. 2005, 90:4457-4464.
7. Dai G., Levy O., Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature 1996, 379:458-460.
8. De la Vieja A., Ginter C.S., Carrasco N. The Q267E mutation in the sodium/iodide symporter (NIS) causes congenital iodide transport defect (ITD) by decreasing NIS turnover. J. Cell. Sci. 2004, 117:677-687.
9. - symporter. Mol. Endocrinol. 2005, 19:2847-2858.
10. + dependence and are critical for transport activity. J. Biol. Chem. 2007, 282:25290-25298.
11. + dependence and are critical for transport activity. J. Biol. Chem. 2007, 282:25290-25298.
12. Dingli D., Diaz R.M., Bergert E.R., O'Connor M.K., Morris J.C., Russell S.J. Genetically targeted radiotherapy for multiple myeloma. Blood 2003, 102:489-496.
13. Dingli D., Russell S.J., Morris J.C. In vivo imaging and tumor therapy with the sodium iodide symporter. J. Cell. Biochem. 2003, 90:1079-1086.
14. Dingli D., Peng K.-W., Harvey M.E., Greipp P.R., O'Connor M.K., Cattaneo R., Morris J.C., Russell S.J. Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter. Blood 2004, 103:1641-1646.
15. - symporter activity requires a small and uncharged amino acid residue at position 395. Mol. Endocrinol. 2002, 16:1893-1902.
16. Dohan O., De la Vieja A., Paroder V., Riedel C., Artani M., Reed M., Ginter C.S., Carrasco N. The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocr. Rev. 2003, 24:48-77.
17. Dohan O., De la Vieja A., Carrasco N. Hydrocortisone and purinergic signaling stimulate NIS-mediated iodide transport in breast cancer cells. Mol. Endocrinol. 2006, 20:1121-1137.
18. Dwyer R.M., Bergert E.R., O'Connor M.K., Gendler S.J., Morris J.C. In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter. Clin. Cancer Res. 2005, 11:1483-1489.
19. Dwyer R.M., Schatz S.M., Bergert E.R., Myers R.M., Harvey M.E., Classic K.L., Blanco M.C., Frisk C.S., Marler R.J., Davis B.J., O'Connor M.K., Russell S.J., Morris J.C. A preclinical large animal model of adenovirus-mediated expression of the sodium-iodide symporter for radioiodie imaging and therapy of locally recurrent prostate cancer. Mol. Ther. 2005, 12:835-841.
20. Dwyer R.M., Bergert E.R., O'Connor M.K., Gendler S.J., Morris J.C. Sodium iodide symporter-mediated radioiodide imaging and therapy of ovarian tumor xenografts in mice. Gene Ther. 2006, 13:60-66.
21. Dwyer R.M., Bergert E.R., O'Connor M.K., Gendler S.J., Morris J.C. Adenovirus-mediated and targeted expression of the sodium-iodide symporter permits in vivo radioiodie imaging and therapy of pancreatic tumors. Hum. Gene Ther. 2006, 17:661-668.
22. Eng P.H.K., Cardona G.R., Fang S.-L., Previti M., Alex S., Carrasco N., Chin W.W., Braverman L.E. Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology 1999, 140:3404-3410.
23. Federman D., Robbins J., Rall J.E. Some observations on cretinism and its treatment. N. Engl. J. Med. 1958, 259:610-613.
24. - symporter. Nat. Genet. 1997, 16:124-125.
25. - symporter in patients with iodide transport defect. J. Clin. Endocrinol. Metab. 1998, 83:2940-2943.
26. Fujiwara H., Tatsumi K., Tanaka S., Kimura M., Nose O., Amino N. A novel V59E missense mutation in the sodium iodide symporter gene in a familiy with iodide transport defect. Thyroid 2000, 10:471-474.
27. Furlanetto T.W., Nguyen L.Q., Jameson J.L. Estradiol increases proliferation and down-regulates the sodium/iodide symporter gene in FRTL-5 cells. Endocrinology 1999, 140:5705-5711.
28. - symporter in human thyroid tissues and salivary gland tissues. Endocrinology 1998, 139:4416-4419.
29. - symporter messenger RNA and protein levels in FRTL-5 rat thyroid cells. Thyroid 1997, 7:789-794.
30. Klutz K., Russ V., Willhauck M.J., Wunderlich N., Zach C., Gildehaus F.J., Göke B., Wagner E., Ogris M., Spitzweg C. Targeted radioiodine therapy of neuroblastoma tumors following systemic non-viral delivery of the sodium iodide symporter (NIS) gene. Clin. Cancer Res. 2009, 15:6079-6086.
31. Kogai T., Schultz J., Johnson L., Huang M., Brent G. Retinoic acid induces sodium/iodide symporter gene expression and radioiodine uptake in the MCF-7 breast cancer cell line. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:8519-8524.
32. Kogai T., Kanamoto Y., Che L.H., Taki K., Moatamed F., Schultz J.J., Brent G.A. Systemic retinoic acid treatment induces sodium/iodide symporter expression and radioiodine uptake in mouse breast cancer models. Cancer Res. 2004, 64:415-422.
33. Kogai T., Kanamoto Y., Li A.I., Che L.H., Ohashi E., Taki K., Chandraratna R.A., Saito T., Brent G.A. Differential regulation of sodium/iodide symporter gene expression by nuclear receptor ligands in MCF-7 breast cancer cells. Endocrinology 2005, 146:3059-3069.
34. Kosugi S., Inoue S., Matsuda A., Jhiang S.M. Novel, missense and loss-of-function mutations in the sodium/iodide symporter gene causing iodide transport defect in three Japanese patients. J. Clin. Endocrinol. Metab. 1998, 83:3373-3376.
35. Kosugi S., Sato Y., Matsuda A., Ohyama Y., Fujieda K., Hiroaki I., Kameya T., Isozaki O., Jhiang S.M. High prevalence of T354P sodium/iodide symporter gene mutation in Japanese patients with iodide transport defect who have heterogeneous clinical pictures. J. Clin. Endocrinol. Metab. 1998, 83:4123-4129.
36. Kosugi S., Bhayana S., Dean H.J. A novel mutation in the sodium/iodide symporter gene in the largest family with iodide transport defect. J. Clin. Endocrinol. Metab. 1999, 84:3248-3253.
37. Kosugi S., Okamoto H., Tamada A., Sanchez-Franco F. A novel peculiar mutation in the sodium/iodide symporter gene in Spanish siblings with iodide transport defect. J. Clin. Endocrinol. Metab. 2002, 87:3830-3836.
38. Kosugi S., Okamoto H., Tamada A., Sanchez-Franco F. A novel peculiar mutation in the sodium/iodide symporter gene in Spanisch siblings with iodide transport defect. J. Clin. Endocrinol. Metab. 2002, 87:3830-3836.
39. - symporter (NIS): recent advances. J. Bioenerget. Biomembr. 1998, 30:195-206.
40. - symporter (NIS) function from analysis of a mutation that causes human congenital hypothyroidism. FEBS Lett. 1998, 429:36-40.
41. Matsuda A., Kosugi S. A homozygous missense mutation of the sodium/iodide symporter gene causing iodide transport defect. J. Clin. Endocrinol. Metab. 1997, 82:3966-3971.
42. Merron A., Peerlinck I., Martin-Duque P., Burnet J., Quintanilla M., Mather S., Hingorani M., Harrington K.J., Iggo R., Vassaux G. SPECT/CT imaging of oncolytic adenovirus propagation in tumours in vivo using the Na/I symporter as a reporter gene. Gene Ther. 2007, 14:1731-1738.
43. - symporter messenger ribonucleic acid levels in FRTL-5 cells. Endocrinology 1998, 139:703-712.
44. Pohlenz J., Medeiros-Neto G., Gross J.L., Silveiro S.P., Knobel M., Refetoff S. Hypothyroidism in a Brazilian kindred due to iodide trapping defect caused by a homozygous mutation in the sodium/iodide symporter gene. Biochem. Biophys. Res. Commun. 1997, 240:488-491.
45. Pohlenz J., Rosenthal I.M., Weiss R.E., Jhiang S.M., Burant C., Refetoff S. Congenital hypothyroidism due to mutations in the sodium/iodide symporter. Identification of a nonsense mutation producing a downstream cryptic 3' splice site. J. Clin. Invest. 1998, 101:1028-1035.
46. Pohlenz J., Refetoff S. Mutations in the sodium/iodide symporter (NIS) gene as a cause for iodide transport defects and congenital hypothyroidism. Biochimie 1999, 81:469-476.
47. Riedel C., Levy O., Carrasco N. Post-transcriptional regulation of the sodium/iodide symporter (NIS) by thyrotropin. J. Biol. Chem. 2001, 276:21458-21463.
48. Scholz I.V., Cengic N., Baker C.H., Harrington K.J., Maletz K., Bergert E.R., Vile R., Göke B., Morris J.C., Spitzweg C. Radioiodine therapy of colon cancer following tissue-specific sodium iodidie symporter gene transfer. Gene Ther. 2005, 12:272-280.
49. Schröder-van der Elst J.P., van der Heide D., Kastelijn J., Rousset B., Obregon M.J. The expression of the sodium/iodide symporter is up-regulated in the thyroid of fetuses of iodine-deficient rats. Endocrinology 2001, 142:3736-3741.
50. Smanik P.A., Liu Q., Furminger T.L., Ryu K., Xing S., Mazzaferri E.L., Jhiang S.M. Cloning of the human sodium iodide symporter. Biochem. Biophys. Res. Commun. 1996, 226:339-345.
51. Smanik P.A., Ryu K.-Y., Theil K.S., Mazzaferri E.L., Jhiang S.M. Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter. Endocrinology 1997, 138:3555-3558.
52. Spitzweg C., Joba W., Eisenmenger W., Heufelder A.E. Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa. J. Clin. Endocrinol. Metab. 1998, 83:1746-1751.
53. Spitzweg C., Joba W., Morris J.C., Heufelder A.E. Regulation of sodium-iodide symporter gene expression in FRTL-5 rat thyroid cells. Thyroid 1999, 9:821-830.
54. Spitzweg C., Joba W., Schriever K., Goellner J.R., Morris J.C., Heufelder A.E. Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands. J. Clin. Endocrinol. Metab. 1999, 84:4178-4184.
55. Spitzweg C., Zhang S., Bergert E.R., Castro M.R., McIver B.D., Heufelder A.E., Tindall D.J., Young C.Y.F., Morris J.C. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines. Cancer Res. 1999, 59:2136-2141.
56. Spitzweg C., O'Connor M.K., Bergert E.R., Tindall D.J., Young C.Y.F., Morris J.C. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter. Cancer Res. 2000, 60:6526-6530.
57. Spitzweg C., Dietz A.B., O'Connor M.K., Bergert E.R., Tindall D.J., Young C.Y.F., Morris J.C. In vivo sodium iodide symporter gene therapy of prostate cancer. Gene Ther. 2001, 8:1524-1531.
58. Spitzweg C., Dutton C.M., Castro M.R., Bergert E.R., Goellner J.R., Heufelder A.E., Morris J.C. Expression of the sodium iodide symporter in human kidney. Kidney Int. 2001, 59:1013-1023.
59. Spitzweg C., Harrington K.J., Pinke L.A., Vile R.G., Morris J.C. The sodium iodide symporter and its potential in cancer therapy. J. Clin. Endocrinol. Metab. 2001, 86:3327-3335.
60. Spitzweg C., Morris J.C. The sodium iodide symporter: its pathophysiological and therapeutic implications. Clin. Endocrinol. 2002, 57:559-574.
61. Spitzweg C., Baker C.H., Bergert E.R., O'Connor M.K., Morris J.C. Image-guided radioiodide therapy of medullary thyroid cancer following carcinoembryonic antigen (CEA)-promoter-targeted sodium iodide symporter (NIS) gene expression. Hum. Gene Ther. 2007, 18:916-924.
62. Stanbury J.B., Chapman E.M. Congenital hypothyroidism with goiter: absence of an iodide-concentrating mechanism. Lancet 1960, 1:1162-1165.
63. Stanbury J.B., Dumont J.E. Familial Goiter and Related Disorders (The Metabolic Basis of Inherited Disease 1983, McGraw-Hill, New York, pp. 231-269.
64. Szinnai G., Kosugi S., Derrien C., Lucidarme N., David V., Czernichow P., Polak M. Extending the clinical heterogeneity of iodide transport defect (ITD): a novel mutation R124H of the sodium/iodide symporter gene and review of genotype-phenotype correlations in ITD. J. Clin. Endocrinol. Metab. 2006, 91:1199-1204.
65. Tatsumi K.-I., Miyai K., Amino N. Genetic basis of congenital hypothyroidism: abnormalities in the TSH beta gene, the PIT1 gene, and the NIS gene. Clin. Chem. Lab. Med. 1998, 36:659-662.
66. Tazebay U.H., Wapnir I.L., Levy O., Dohan O., Zuckier L.S., Zhao Q.H., Deng H.F., Amenta P.S., Fineberg S., Pestell R.G., Carrasco N. The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat. Med. 2000, 6:871-878.
67. Tonacchera M., Agretti P., De Marco G., Elisei R., Perri A., Ambrogini E., De Servi M., Cecarelli C., Viacava P., Refetoff S., Panunzi C., Bitti M.L.M., Vitti P., Chiovato L., Pinchera A. Congenital hypothyroidism due to a new deletion in the sodium/iodide symporter protein. Clin. Endocrinol. 2003, 59:500-506.
68. Unterholzner S., Willhauck M.J., Cengic N., Schütz M., Göke B., Morris J.C., Spitzweg C. Dexamethasone stimulation of retinoic acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells. J. Clin. Endocrinol. Metab. 2006, 91:69-78.
69. - symporter mRNAs in dog thyroid. Mol. Cell. Endocrinol. 1997, 131:195-203.
70. Van Sande J., Massart C., Beauwens R., Schoutens A., Costagliola S., Dumonat J.E., Wolff J. Anion selectivity by the sodium iodide symporter. Endocrinology 2003, 144:247-252.
71. Willhauck M.J., Sharif Samani B., Gildehaus F.J., Wolf I., Senekowitsch-Schmidtke R., Stark H.J., Göke B., Morris J.C., Spitzweg C. Application of 188Re as an alternative radionuclide for treatment of prostate cancer after tumor-specific sodium iodide symporter gene expression. J. Clin. Endocrinol. Metab. 2007, 92:4451-4458.
72. Willhauck M.J., Sharif-Samani B.R., Klutz K., Cengic N., Wolf L., Mohr L., Geissler M., Senekowitsch-Schmidtke R., Göke B., Morris J.C., Spitzweg C. Alpha fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma. Gene Ther. 2008, 15:214-223.
73. Willhauck M.J., Sharif-Samani B., Senekowitsch-Schmidtke R., Wunderlich N., Göke B., Morris J.C., Spitzweg C. Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone. Breast Cancer Res. Treat. 2008, 109:263-272.
74. Willhauck M.J., Sharif-Samani B., Wolf I., Senekowitsch-Schmidtke R., Stark H.J., Meyer G.J., Knapp W.H., Göke B., Morris J.C., Spitzweg C. The potential of astatine-211 for NIS-mediated radionuclide therapy in prostate cancer. Eur. J. Nucl. Med. Mol. Imaging 2008, 35:1272-1281.
75. Wolff J., Chaikoff I.L. Plasma inorganic iodide as a homeostatic regulator of thyroid function. J. Biol. Chem. 1948, 174:555-564.
76. Wolff J., Chaikoff I.L., Goldberg R.C., Meier J.R. The temporary nature of the inhibitory action of excess iodide on organic iodine synthesis in the normal thyroid. Endocrinology 1949, 45:504-513.
77. Wolff J. Congenital goiter with defective iodide transport. Endocr. Rev. 1983, 4:240-254.